Synthetic Biology Market to Surpass USD 67.47 Billion by 2033, Fueled by 20.9% CAGR and Breakthroughs in CRISPR, mRNA Vaccines, and Sustainable Bio-Solutions

According to DataM Intelligence,the Synthetic Biology Market reached US$ 12.37 Billion in 2024 and is expected to reach US$ 67.47 Billion by 2033, growing at a CAGR of 20.9% from 2025 to 2033.

The Synthetic Biology Market involves the design and construction of new biological parts, devices, and systems, or the redesign of existing biological systems for useful purposes. It integrates biology, engineering, and computational sciences, leveraging technologies like CRISPR-Cas9, synthetic DNA, and genome editing. The market serves applications in healthcare (vaccines, diagnostics, personalized medicine), industrial biotechnology (biofuels, bioplastics), agriculture, food, animal health, and environmental solutions, catering to pharmaceutical, biotech, industrial, and academic sectors.

📌 Access valuable insights with our sample report - (Please enter your Corporate Email ID to get priority access):
https://www.datamintelligence.com/download-sample/synthetic-biology-market?sindhuri

☛ Synthetic Biology Market Forces Driving Future Growth

The synthetic biology market is driven by increasing demand for sustainable bio-based solutions, such as biofuels and bioplastics, and breakthroughs in medical applications like CRISPR-based therapies (e.g., CRISPR Therapeutics' exa-cel for sickle cell disease) and mRNA vaccines (e.g., Moderna's platform).

Innovations like Organovo's 3D-printed tissues for drug testing and biohybrid microswimmers for targeted drug delivery further fuel growth. Strong government funding (e.g., NIH, DARPA) and venture capital investments in regions like North America support R&D and commercialization.

Challenges include ethical concerns over "synthetic life," biosafety risks of engineered organisms escaping into ecosystems, and biosecurity fears of misuse for harmful pathogens, leading to stricter regulations. Public skepticism toward lab-grown products, like cultivated meat, also slows adoption.

Opportunities include expanding applications in precision medicine, environmental sustainability, and agriculture, particularly in Asia-Pacific, where genetic diversity and government initiatives drive rapid growth. Initiatives like RootPath's Megabase Spark, providing free synthetic DNA for research, further accelerate innovation.

☛ Synthetic Biology Industry News

Product Launches: In May 2025, Ribbon Bio GmbH launched MiroSynth DNA, a high-accuracy synthetic DNA product for biopharma and research. Twist Bioscience's "Express Genes" service (2023) offers rapid gene synthesis in 5-7 days.

Initiatives: RootPath's Megabase Spark (May 2025) aims to provide 3 million base pairs of synthetic DNA by 2026 to support underfunded research.

Acquisitions: Eli Lilly acquired Organovo's FXR program in 2025, leveraging 3D-printed tissues for drug testing.

Collaborations: Partnerships between academic hubs (e.g., Innovative Genomics Institute) and biotech firms drive advancements in CRISPR therapies.

☛ Synthetic Biology Market: Industry Giants and Emerging Leaders
» Illumina, Inc.
» Merck KGaA
» Thermo Fisher Scientific Inc.
» Bota Biosciences
» Codexis, Inc.
» Twist Bioscience
» Creative Biogene
» Eurofins Genomics

Research Methodology
Our research methodology integrates qualitative and quantitative approaches to deliver reliable market intelligence. We conduct thorough secondary research using trusted industry publications, proprietary databases, and credible market sources, complemented by primary research involving structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Speak to Our Senior Analyst and Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/synthetic-biology-market

☛ Segments Covered in the Synthetic Biology Market

By Product Type
Oligonucleotides and Synthetic DNA dominate with a 34.12% share in 2024, driven by their critical role in research, diagnostics, and therapeutics, with innovations like Ribbon Bio's MiroSynth DNA and Twist Bioscience's rapid synthesis services. Other segments include Enzymes, Cloning Technologies Kits, Synthetic Cells, Xeno-Nucleic Acids, Chassis Organism, and Others.

By Technology
Genome Engineering leads due to advancements in CRISPR and gene editing. Other technologies include Sequencing, Bioinformatics, Cloning, Nanotechnology, and Others, supporting diverse applications.

By Application
Medical Applications hold the largest share (54.21% in 2024), driven by precision medicine, vaccines, and therapies like exa-cel and mRNA platforms. Other applications include Industrial Applications, Food and Animal Health, Agricultural Applications, Environmental Applications, and Others.

By End User
Pharmaceutical & Biotechnology Companies lead due to heavy R&D investments, followed by Industrial & Chemical Companies, Food & Beverage Companies, Academic and Research Institutes, and Others.

☛ This Report Covers
✔ Go-to-market Strategy.
✔ Neutral perspective on market performance.
✔ Development trends, competitive landscape analysis, supply-side analysis, demand-side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analyses.
✔ Customized regional/country reports as per request and country-level analysis.
✔ Potential & niche segments and regions exhibiting promising growth.
✔ Top-down and bottom-up approach for regional analysis.

📌 Buy Now & Unlock 360° Market Intelligence:

https://www.datamintelligence.com/buy-now-page?report=synthetic-biology-market

☛ Regional Analysis for Synthetic Biology Market
⇥ North America (U.S., Canada, Mexico) - Dominates with a 42.52% share in 2024, driven by robust funding from NIH, DARPA, and biotech hubs like Boston and San Francisco.
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands, Rest of Europe) - Growing due to research collaborations and biotech advancements.
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia, Rest of Asia Pacific) - Fastest-growing region with a 21.1% CAGR, fueled by genetic diversity and government investments.
⇥ South America (Colombia, Brazil, Argentina, Rest of South America) - Emerging market with increasing biotech adoption.
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa) - Steady growth with expanding research infrastructure.

📌 Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription

☛ Power Your Decisions with Real-Time Insights
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We leverage our top trademark trends, insights, and developments to deliver swift and astute solutions to clients. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries, catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.